ODESSA, FL, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Dais Analytic Corporation (OTCQB: DLYT), a commercial nanotechnology materials business selling its industry-changing nanomaterial technology into the worldwide water, air and energy markets, announced that it has partnered with Umore Consulting, a global firm focused on clean technology transfer and financial services, headquartered in Shanghai, to assist in funding and establishing a Dais subsidiary in the People’s Republic of China.
The Company signaled, with the signing of this agreement, the need to have an in-country subsidiary to grow its business interests in China. The expansion is projected to come from a more concentrated focus to increase the sales (and servicing) of Aqualyte™ nanomaterial, NanoClear™ industrial waste water treatment systems, and ConsERV™ components or systems for heating, ventilating, and air-conditioning (HVAC) energy and CO2 savings.
It is anticipated over time this subsidiary will serve as a base for sales in the broader Southeast Asian market. It is Dais’s plan to have this subsidiary provide key functions such as in-country management, marketing, business development and sales support, technical support, and manufacturing focused on a more rapid and efficient expansion of Dais’s business in China which it has identified as a strategic growth market.
“The strategic partnership between Dais Analytic and Umore brings the strengths of our two companies together addressing the growing market opportunities for Dais's nanomaterial technology in the clean air, energy, and water industries. The key deliverable of our partnering is funding and a functional in-country business entity tasked solely to grow revenue, partnerships, and manufacturing in the local China markets,” said Rong Xu, CEO of Umore Consulting.
“We are pleased to announce Dais is partnering with Umore, a capable and well-known firm in the cleantech industry. We believe our efforts and skills will combine to create this Dais subsidiary in China, and to extend our successes to date in partnering, licensing and selling product into multiple sales channels in the important China market. It is the next logical step to more rapidly accelerate revenues from the sale of our innovative, state-of-the-art, proprietary products. This announcement solidifies our commitment to China,” says Tim Tangredi, Dais’s CEO.
Dais projects it will continue to grow throughout 2018 as it sets its sights on a conventional capital raise and planned future up-listing to a national securities exchange such as the NASDAQ Capital Market.
About Umore Consulting
Umore Consulting is a global consulting firm focused on cleantech transfer and financial services. Umore is committed to fostering collaborations across environmental government agencies, private equities, venture capitals, and technological small to medium-sized enterprises to assist companies in driving sustainable business growth. With a global platform and industrial research capacity, Umore provides full-dimension and customized solutions in connecting local partners with international companies and supporting a smooth landing to the Chinese market in terms of merger and acquisition, business development and strategic partnership.
Established in 2014 and headquartered in Shanghai, Umore became the earliest cleantech transfer platform in China. Thus far, Umore has set up four representative offices in Copenhagen, Dusseldorf, Toronto, and Singapore for scouting top-notch clean technologies across 14 countries. With respect to governmental partnership, Umore has strategically aligned with NETC (National Eastern Tech-Transfer Center) and FECO (Foreign Economic Cooperation Office, Ministry of Environmental Protection). Besides, Umore is a member of CTCN, the operational arm of the UNFCCC Technology Mechanism, hosted by the UN Environment Programme (UNEP) and the UN Industrial Development Organization (UNIDO).
About Dais Analytic Corporation
Dais Analytic Corporation (OTCQB: DLYT) is a nanotechnology business producing a versatile family of membrane materials - called Aqualyte™- focusing on evolutionary or disruptive air, energy and water applications. The uses include:
- NanoClear™, a commercialized system treating contaminated industrial waste water providing ultra-pure potable water with higher system efficiencies at equal or better capital and operating costs than other technologies.
- ConsERV™, a commercially available engineered energy recovery ventilator that uses stale air being exhausted to precondition the temperature and moisture content of the incoming fresh ventilation air, typically saving energy, reducing CO2 emissions, and allowing for equipment downsizing;
- PolyCool™, an Aqualyte™-based next generation evaporative cooling technology that is nearing full commercialization. Aqualyte is configured for use in cooling towers and evaporative condensers for cooling uses in traditional HVAC, waste water treatment, and power systems industries providing reduced energy and operating costs. Other key features include preventing release of dangerous microbes such as Legionella, and opening new markets for smaller air-cooled HVAC systems.
- NanoAir™, a water-based cooling cycle with no fluorocarbon refrigerants that is in early beta-stage testing which can replace existing vapor compression cooling cycles in most forms of air-conditioning and refrigeration, saving a projected 50% in energy and CO2.
Each use demonstrates the diversity of Dais' core product, Aqualyte™, a family of nanostructured polymers and engineered processes focused on minimizing consumption of irreplaceable natural resources and ending the degradation of our environment. To find out more about Dais please visit www.daisanalytic.com.
Safe Harbor Statement
This press release includes statements that may constitute forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," and similar statements. Statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. For example, statements about future revenues and the Company’s ability to fund its operations and contractual obligations are forward looking and subject to risks. Several important factors could cause actual results to differ materially from those contained in any forward-looking statement. Potential risks and uncertainties include, but are not limited to, the inability to raise capital to support the Company through its growth stage, the Company’s inability to generate projected sales and trade relations between the United States and China. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.